Fetal effects of cervical ripening with extra-amniotic prostaglandin E2 in gel.
A gel containing 0.5 mg prostaglandin E2 (PGE2) was extra-amniotically instilled 90 clinically normal gravidae at term, for ripening of the cervix before elective induction of labor by amniotomy and intravenous PGE2. An acceptable increase in the Bishop score was noted to have occurred in 87/90 women, when assessed eight hours after administration of the gel; 14 of these women were then in established labor, which progressed uneventfully. Four of the 90 subjects required cesarean section for cephalopelvic disproportion. No adverse maternal or fetal effects of the procedure were detected under careful clinical, electronic and biochemical monitoring. However, epidural anesthesia adversely influenced the acid-base equilibrium of the fetus.
D000137:Acid-Base Imbalance / Q000139:chemically induced; D000767:Anesthesia, Epidural / Q000009:adverse effects; D001034:Apgar Score; D002584:Cervix Uteri / Q000187:drug effects*; D005260:Female; D005782:Gels; D006801:Humans; D007231:Infant, Newborn; D007751:Labor, Induced; D008431:Maternal-Fetal Exchange / Q000187:drug effects*; D011247:Pregnancy; D011458:Prostaglandins E / Q000627:therapeutic use*
D005782:Gels; D011458:Prostaglandins E